Prospects for the therapeutic use of antigene oligonucleotides

Cancer Investigation

Volumn 14, Issue 1, 1996, Pages 66-82

  Maher III, L James ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

CANCER; GENE THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 0029873110     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609018437     Document Type: Review

References (165)

1. Cohen JS: Oligodeoxynucleotides: Antisense Inhibitors of Gene Expression. Boca Raton, FL, CRC Press, 1989.
2. Goodchild J: Conjugates of oligonucleotides and modified oligonucleotides: A review of their syntheses and properties. Bioconj Chem 1:165-187, 1990.
3. Uhlmann E, Peyman A: Antisense oligonucleotides: A new therapeutic principle. Chem Rev 90:543-584, 1990.
4. Wickstrom E: Prospects for Antisense Nucleic acid Therapy of Cancer and AIDS. New York, Wiley-Liss, 1991.
5. Stein CA, Cheng Y-C: Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 261:1004-1012, 1993.
6. Dervan PB: Design of sequence-specific DNA-binding molecules. Science 232:464-471, 1986.
7. Kosturko LD, Dattagupta N, Crothers DM: Selective repression of transcription by base sequence specific synthetic polymers. Biochemistry 18:5751-5756, 1979.
8. Minton KW: The triple helix: A potential mechanism for gene regulation. J Exp Pathol 2:135-148, 1985.
9. Nielsen PE: Sequence-selective DNA recognition by synthetic ligands. Bioconj Chem2:1-12, 1991.
10. Nielsen PE, Egholm M, Berg RH, et al: Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254:1497-1500, 1991.
11. Egholm M, Buchardt O, Nielsen PE, et al: Peptide nucleic acids (PNA): Oligonucleotide analogues with an achiral peptide backbone. J Am Chem Soc 114:1895-1897, 1992.
12. Egholm M, Buchardt O, Christensen L, et al: PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365:566-568, 1993.
13. Nielsen PE, Egholm M, Buchardt O: Peptide nucleic acid (PNA): A DNA mimic with a peptide backbone. Bioconj Chem. 5:3-5, 1994.
14. Hélène C: Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer 27:1466-1471, 1991.
15. Hélène C: The anti-gene strategy: Control of gene expression by triplex-forming-oligonucleotides. Anti-Cancer Drug Design 6:569-584, 1991.
16. Maher LJ III, Dervan PB, Wold B: Inhibition of DNA/protein interactions by oligonucleotide-directed DNA triple helix formation: Progress and prospects. In: Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS, edited by E Wickstrom, New York, Wiley-Liss, 1991, pp. 227-242.
17. Gee JE, Miller DM: Structure and applications of intermolecular DNA triplexes. Am J Med Sci 304:366-372, 1992.
18. Maher LJ: DNA triple helix formation: An approach to artificial gene repressors? BioEssays 14:807-815, 1992.
19. Thuong NT, Hélène C: Sequence-specific recognition and modification of double-helical DNA by oligonucleotides. Angew Chem Ed Engl 32:666-690, 1993.
20. Felsenfeld G, Davies DR, Rich A: Formation of a three-stranded polynucleotide molecule. J Am Chem Soc 79:2023-2024, 1957.
21. Lipsett MN: The interactions of poly(C) and guanine trinucleotides. Biochem Biophys Res Commun 11:224-228, 1963.
22. Howard FB, Frazier J, Lipsett MN, et al: Infrared demonstration of two- and three-strand helix formation between poly(C) and guanosine mononucleotides and oligonucleotides. Biochem Biophys Res Commun 17:93-102, 1964.
23. Lipsett MN: Complex formation between polycytidylic acid and guanine oligonucleotides. J Biol Chem 239:1256-1260, 1964.
24. Morgan AR, Wells RD: Specificity of the three-stranded complex formation between double stranded DNA and single-stranded RNA containing repeating nucleotide sequences. J Mol Biol 37: 63-80, 1968.
25. n DNAs on lowering the pH are three-stranded. Nucleic Acids Res 6:3073-3091, 1979.
26. Arnott S, Bond PJ: Structures for poly(U)•poly(A)•poly(U) triple stranded polynucleotides. Nature New Biol 244:99-101, 1973.
27. Arnott S, Hukins DWL, Dover SD, et al: Structures of synthetic polynucleotides in the A-RNA and A'-RNAconformations: X-ray diffraction analyses of the molecular conformations of polyadenylic acid-polyuridylic acid and polyinosinic acid-polycytidylic acid. J Mol Biol 81:107-122, 1973.
28. Arnott S, Selsing E: Structures for the polynucleotide complexes poly(dA)•poly(dT) and poly(dT)•poly(dA)•poly(dT). J Mol Biol 88:509-521, 1974.
29. Arnott S, Bond PJ, Selsing E, et al: Models of triple-stranded polynucleotides with optimised stereochemistry. Nucleic Acids Res 3:2459-2470, 1976.
30. Rich A: Formation of two- and three-stranded helical molecules by polyinosinic acid and polyadenylic acid. Nature 181:521-525, 1958.
31. MarckC, Thiele D: Poly(dG)-poly(dC) at neutral and alkaline pH: The formation of triple-stranded poly(dG)-poly(dG)-poly(dC). Nucleic Acids Res 5:1017-1028, 1978.
32. Broitman SL, Im DD, Fresco JR: Formation of the triple-stranded polynucleotide helix, poly(A•A•U). Proc Natl Acad Sci USA 84:5120-5124, 1987.
33. Cantor CR, Schimmel PR: Biophysical Chemistry, Vol I, San Francisco, Freeman, 1980, pp 186-196.
34. Letai AG, Palladino MA, Fromm E, et al: Specificity in formation of triple-stranded nucleic acid helical complexes: Studies with agarose linked polyribonucleotide affinity columns. Biochemistry 27:9108-9112, 1988.
35. Britten RJ, Davidson EH: Gene regulation for higher cells: A theory. Science 165:349-357, 1969.
36. Miller JH, Sobell HM: A molecular model for gene repression. Proc Natl Acad Sci USA 55:1201-1205, 1966.
37. Bina M, Feldmann RJ, Deeley RG: Could poly(A) align the splicing sites of messenger RNA precursors? Proc Natl Acad Sci USA 77:1278-1282, 1980
38. Rich A: The molecular structure of polyinosinic acid. Biochim Biophys Acta 29:502-509, 1958.
39. Rich A: A hybrid helix containing both deoxyribose and ribose polynucleotides and its relation to the transfer of information between the nucleic acids. Biochemistry 46:1044-1053, 1960.
40. Arnott S, Bond PJ: Triple-stranded polynucleotide helix containing only purine bases. Science 181:68, 1973.
41. Lee JS, Woodsworth ML, Latimer LJP, et al: Poly(pyrimidine)•poly(purine) synthetic DNAs containing 5-methylcytosine form stable triplexes at neutral pH. Nucleic Acids Res 12:6603-6614, 1984.
42. Lee JS, Burkholder GD, Latimer LJP, et al. A monoclonal antibody to triplex DNA binds to eucaryotic chromosomes. Nucleic Acids Res 15:1047-1061, 1987.
43. Moser HE, Dervan PB: Sequence-specific cleavage of double helical DNA by triple helix formation. Science 238:645-650, 1987.
44. Le Doan T, Perrouault L, Praseuth D, et al: Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[α]-thymidylate covalently linked to an azidoproflavine derivative Nucleic Acids Res 15:7749-7760, 1987.
45. Praseuth D, Perrouault L, Le Doan T, et al: Sequence-specific binding and photocrosslinking of α and β oligodeoxynucleotides to the major groove of DNA via triple-helix formation. Proc Natl Acad Sci USA 85:1349-1353, 1988.
46. Lyamichev VI, Mirkin SM, Frank-Kamenetskii MD, et al: A stable complex between homopyrimidine oligomers and the homologous regions of duplex DNAs. Nucleic Acids Res 16:2165-2178, 1988.
47. Cooney M, Czernuszewicz G, Postel EH, et al: Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science 241:456-459, 1988.
48. Beal PA, Dervan PB: Second structural motif for recognition of DNA by oligonucleolide-directed triple-helix formation. Science 251:1360-1363, 1991.
49. Durland RH, Kessler DJ, Hogan M: Antiparallel triplex formation at physiological pH. In: Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS, edited by E Wickstrom, New York, Wiley-Liss, 1991, pp 219-226.
50. Plum GE, Park Y-W, Singleton SF, et al: Thermodynamic characterization of the stability and the melting behavior of a DNA triplex: A spectroscopic and calorimetric study. Proc Natl Acad Sci USA 87:9436-9440, 1990.
51. Mergny J-L, Sun J-S, Rougee M, et al: Sequence specificity in triple-helix formation: Experimental and theoretical studies of the effects of mismatches on triplex stability. Biochemistry 30:9791-9798, 1991.
52. Pilch DS, Levenson C, Shafer RH: Structure, stability, and thermodynamics of a short intermolecular purine-purine-pyrimidine triple helix. Biochemistry 30:6081-6087, 1991.
53. Singleton SF, Dervan PB: Equilibrium association constants for oligonucleotide-directed triple helix formation at single DNA sites: Linkage to cation valence and concentration. Biochemistry 32:13171-13179, 1993.
54. Singleton SF, Dervan PB: Influence of pH on the equilibrium association constants for oligodeoxyribonucleotide-directed triple helix formation at single DNA sites. Biochemistry 31:10995-11003, 1992.
55. Maher LJ, Dervan PB, Wold BJ: Kinetic analysis of oligodeoxyribonucleotide-directed triple-helix formation on DNA. Biochemistry 29:8820-8826, 1990.
56. Durland RH, Kessler DJ, Gunnell S, et al: Binding of triple helix forming oligonucleotides to sites in gene promoters. Biochemistry 30:9246-9255, 1991.
57. Rougée M, Faucon B, Mergny JL, et al: Kinetics and thermodynamics of triple-helix formation: Effects of ionic strength and mismatches. Biochemistry 31:9269-9278, 1992.
58. Povsic TJ, Dervan PB: Triple helix formation by oligonucleotides on DNA extended to the physiological pH range. J Am Chem Soc 111:3059-3061, 1989.
59. Hampel KJ, Crosson P, Lee JS: Polyamines favor DNA triplex formation at neutral pH. Biochemistry 30:4455-4459, 1991.
60. Sun JS, Giovannangeli C, François JC, et al: Triple-helix formation by α oligodeoxynucleotides and α oligodeoxynucleotide-intercalator conjugates. Proc Natl Acad Sci USA 88:6023-6027, 1991.
61. Shimizu M, Konishi A, Shimada Y, et al: Oligo(2′-Ο-methyl)ribonucleotides: Effective probes for duplex DNA. FEBS Lett 302:155-158, 1992.
62. Strobel SA, Moser HE, Dervan PB: Double-strand cleavage of genomic DNA at a single site by triple-helix formation. J Am Chem Soc 110:7927-7929, 1988.
63. Griffin LC, Dervan PB: Recognition of thymine-adenine base pairs by guanine in a pyrimidine triple helix motif. Science 245:967-971, 1989.
64. Rajagopal P, Feigon J: Triple-strand formation in the homopurine:homopyrirmdine DNA oligonucleotides d(G-A)4 and d(T-C)4. Nature 339:637-640, 1989.
65. Maher LJ, Wold B, Dervan PB: Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science 245:725-730, 1989.
66. François J-C, Saison-Behmoaras T, Thuong NT, et al: Inhibition of restriction endonuclease cleavage via triple helix formation by homopyrimidine oligonucleotides. Biochemistry 28:9617-9619, 1989.
67. Hanvey JC, Shimizu M, Wells RD: Site-specific inhibition of EcoRI restriction/modification enzymes by a DNA triple helix. Nucleic Acids Res 18:157-161, 1989.
68. Perrouault L, Asseline U, Rivalle C, et al: Sequence-specific artificial photo-induced endonucleases based on triple helix-forming oligonucleotides. Nature 344:358-360, 1990.
69. Povsic TJ, Dervan PB: Sequence-specific alkylation of double-helical DNA by oligonucleotide-directed triple-helix formation. J Am Chem Soc 112:9428-9430, 1990.
70. Home DA, Dervan PB: Recognition of mixed-sequence duplex DNA by alternate-strand triple-helix formation. J Am Chem Soc 112:2435-2437, 1990.
71. Shea RG, Ng P, Bischofberger N: Thermal denaturation profiles and gel mobility shift analysis of oligodeoxynucleoside triplexes. Nucleic Acids Res 18:4859-4866, 1990.
72. Birg F, Praseuth D, Zerial A, et al: Inhibition of simian virus 40 DNA replication in CV-1 cells by an oligodeoxynucleotide covalently linked to an intercalating agent. Nucleic Acids Res 18: 2901-2907, 1990.
73. Strobel SA, Dervan PB: Site-specific cleavage of a yeast chromosome by oligonucleotide-directed triple-helix formation. Science 249:73-75, 1990.
74. n DNA triplexes in solution: Imino and aroino proton and nitrogen markers of G•TA base triple formation. Biochemistry 30:9022-9030, 1991.
75. Takasugi M, Guendouz A, Chassignal M, et al: Sequence-specific photo-induced cross-linking of the two strands of double-helical DNA by a psoralen covalently linked to a triple helix-forming oligonucleotide. Proc Natl Acad Sci USA 88: 5602-5606, 1991.
76. Pei D, Schultz PG: Engineering protein specificity: gene manipulation with semisynthetic nucleases. J Am Chem Soc 113:9398-9400, 1991.
77. Home DA, Dervan PB: Effects of an abasic site on triple helix formation characterized by affinity cleaving. Nucleic Acids Res 19:4963-4965, 1991.
78. Macaya RF, Gilbert DE, Malek S, et al: Structure and stability of X•G•C mismatches in the third strand of intramolecular triplexes.Science 254:270-274, 1991.
79. Postel EH, Flint SJ, Kessler DJ, et al: Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels. Proc Natl Acad Sci USA 88:8227-8231, 1991.
80. Orson FM, Thomas DW, McShan WM, et al: Oligonucleotide inhibition of EL2Rα mRNA transcription by promoter region collinear triplex formation in lymphocytes. Nucleic Acids Res 19:3435-3441, 1991.
81. Roberts RW, Crothers DM: Specificity and stringency in DNA triplex formation. Proc Natl Acad Sci USA 88:9397-9401, 1991.
82. Matteucct M, Lin K-Y, Butcher S, et al: Deoxyoligonucleotides bearing neutral analogs of phosphodiester linkages recognize duplex DNA via triple-helix formation. J Am Chem Soc 113:7767-7768, 1991.
83. Ono A, Ts'o POP, Kan L-S: Triplex formation of oligonucleotides containing 2′-Ο-methylpseudoisocytidine in substitution for 2′-deoxycytidine. J Am Chem Soc 113:4032-4333, 1991.
84. Young SL, Krawczyk SH, Matteucci MD, et al: Triple helix formation inhibits transcription elongation in vitro. Proc Natl Acad Sci USA 88:10023-10026, 1991.
85. Strobel SA, Dervan PB: Single-site enzymatic cleavage of yeast chromosomal DNA mediated by triple helix formation. Nature 350:172-174, 1991.
86. Strobel SA, Doucette-Stamm LA, Riba L, et al: Site-specific cleavage of human chromosome 4 mediated by triple-helix formation. Science 254:1639-1642, 1991.
87. Pei D, Ulrich HD, Schulte PG: A combinatorial approach toward DNA recognition. Science 253:1408-1411, 1991.
88. n) tracts: Recognition of alternate strands via Pu•PuPy and Py•PuPy base triplets. Biochemistry 31:320-327, 1992.
89. Jayasena SD, Johnston BH: Oligonucleotide-directed triple helix formation at adjacent oligopurine and oligopyrimidine DNA tracts by alternate strand recognition. Nucelic Acids Res 20:5279-5288, 1992.
90. Beal PA, Dervan PB: Recognition of double helical DNA by alternate strand triple helix formation. J Am Chem Soc 114:4976-4982, 1992.
91. Beal PA, Dervan PB: The influence of single base triplet changes on the stability of a pur•pur•pyr triple helix determined by affinity cleaving. Nucleic Acids Res 20:2773-2776, 1992.
92. Johnson KH, Durland RH, Hogan ME: The vacuum UV CD spectra of G•G•C triplexes. Nucleic Acids Res 20:3859-3864, 1992.
93. +-type DNA triple helix by molecular modelling. Nucleic Acids Res 20:6535-6541, 1992.
94. Cheng Y-K, Pettitt BM: Stabilities of double- and triple-strand helical nucleic acids. Prog Biophys Mol Biol 58:225-257, 1992.
95. Radhakrishnan I, Patel DJ: Solution conformation of a G•TA triple in an intramolecular pyrimidine•purine•pyrimidine DNA triplex. J Am Chem Soc 114:6913-6915, 1992.
96. Radhakrishnan I, Patel DJ: Three-dimensional homonuclear NOESY-TOCSY of an intramolecular pyrimidine•purine•pyrimidine DNA triptex containing a central G•TA triple: Nonexchangeable proton assignments and structural implications. Biochemistry 31:2514-2523, 1992.
97. Kiessling LL, Griffin LC, Dervan PB: Flanking sequence effects within the pyrimidine triple-helix motif characterized by affinity cleaving. Biochemistry 31:2829-2834, 1992.
98. Giovannangéli C, Rovgée M, Garestier T, et al: Triple-helix formation by oligonucleotides containing the three bases thymine, cytosine, and guanine. Proc Natl Acad Sci USA 89:8631-8635, 1992.
99. Mergny JL, Duval-Valentin G, Nguyen CH, et al: Triple helix-specific ligands. Science 256:1681-1684, 1992.
100. Roberts RW, Crothers DM: Stability and properties of double and triple helices: Dramatic effects of RNA or DNA backbone composition. Science 258:1463-1466, 1992.
101. Lu G, Ferl RJ: Site-specific oligodeoxynucleotide binding to maize Adh1 gene promoter represses Adh1-GUS gene expression in vivo. Plant Mol Biol 19:715-723, 1992.
102. Blume SW, Gee JE, Shrestha K, et al: Triple helix formation by purine-rich oligonucleotides targeted to the human dihydrofolate reductase promoter. Nucleic Acids Res 20:1777-1784, 1992.
103. Gee JE, Blume S, Snyder RC, et al: Triplex formation prevents Sp1 binding to the dihydrofolate reduetase promoter. J Biol Chem 267:11163-11167, 1992.
104. Maher LJ, Dervan PB, Wold B: Analysis of promoter-specific repression by triple-helical DNA complexes in a eukaryotic cell-free transcription system. Biochemistry 31:70-81, 1992.
105. Chomilier J, Sun J-S, Collier DA, et al: A computational and experimental study of the bending induced at a double-triple helix junction. Biophys Chem 45:143-152, 1992.
106. Maher LJ: Inhibition of T7 RNA polymerase initiation by triple-helical DNA complexes: A model for artificial gene regulation. Biochemistry 31:7587-7594, 1992.
107. Ross C, Samuel M, Broitman SL: Transcriptional inhibition of the bacteriophage T7 early promoter region by oligonucleotide triple helix formation. Biochem Biophys Res Commun 189:1674-1680, 1992.
108. Duval-Valentin G, Thuong NT, Hélène C: Specific inhibition of transcription by triple helix-forming oligonucleotides. Proc Natl Acad Sci USA 89:504-508, 1992.
109. Grigoriev M, Praseuth D, et al: A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional represser via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence. J Biol Chem 267:3389-3395, 1992.
110. Ito T, Smith CL, Cantor CR: Triplex affinity capture of a single copy clone from a yeast genomic library. Nucleic Acids Res 20:3524, 1992.
111. Takabatake T, Asada K, Uchimura Y, et al: The use of purine-rich oligonucleotides in triplex-mediated DNA isolation and generation of unidirectional deletions. Nucleic Acids Res 20:5853-5854, 1992.
112. Koh JS, Dervan PB: Design of a nonnatural deoxyribonucleoside for recognition of GC base pairs by oligonucleotide-directed triple helix formation. J Am Chem Soc 114:1470-1478, 1992.
113. Griffin LC, Kiessling LL, Beal PA, et al: Recognition of all four base pairs of double-helical DNA by triple-helix formation: Design of nonnatural deoxyribonucleosides for pyrimidine•purine base pair binding. J Am Chem Soc 114:7976-7982, 1992.
114. Froehler BC, Ricca DJ: Triple-helix formation by oligodeoxynucleotides containing carbocyclic analogs of thymidine and 5-methyl-2′-deoxycytidine. J Am Chem Soc 114:8320-8322, 1992.
115. Cheng A-J, Van Dyke MW: Monovalent cation effects on intermolecular purine-purine-pyrimidine triple-helix formation. Nucleic Acids Res 21:5630-5635, 1993.
116. Milligan JF, Krawczyk SH, Wadwani S, et al: An anti-parallel triple helix motif with oligodeoxynucleotides containing 2′-deoxyguanosine and 7-deaza-2′-deoxyxanthosine. Nucleic Acids Res 21:327-333, 1993.
117. +-containing DNA triplexes. Biochemistry 32: 5591-5597, 1993.
118. Pilch DS, Martin M-T, Nguyen CH, et al: Self-association and DNA-binding properties of two triple helix-specific ligands: Comparison of benzo[e]pyridoindole and benzo[g]pyridoindole. J Am Chem Soc 115:9942-9951, 1993.
119. Wilson WD, Tanious FA, Mizan S, et al: DNA triple-helix specific intercalators as antigene enhancers: Unfused aromatic cations. Biochemistry 32:10614-10621, 1993.
120. Ye X, Kimura K, Patel DJ: Site-specific intercalation of an anthracyclic antibiotic into a Y•RY DNA triplex through covalent adduct formation. J Am Chem Soc 115:9325-9326, 1993.
121. Koshlap KM, Gillespie P, Dervan PB, et al: Nonnatural deoxyribonucleoside D3 incorporated in an intramolecular DNA triplex binds sequence-specifically by intercalation. J Am Chem Soc 115:7908-7909, 1993.
122. 4-(6-aminopyridinyl)-2′-deoxycytidine. J Am Chem Soc 115:10456-10457, 1993.
123. Stilz HU, Dervan PB: Specific recognition of CG base pairs by 2-deoxynebularine within the purine•purine•pyrimidine triple helix motif. Biochemistry 32:2177-2185, 1993
124. Skoog JU, Maher LJ: Repression of bacteriophage promoters by DNA and RNA oligonucleotides. Nucleic Acids Res 21:2131-2138, 1993.
125. Escudé C, François J-C, Sun J-S, et al: Stability of triple helices containing RNA and DNA strands: Experimental and molecular modeling studies. Nucelic Acids Res 21:5547-5553, 1993.
126. Cherny DI, Malkov VA, Volodin AA, et al: Electron microscopy visualization of oligonucleotide binding to duplex DNA via triplex formation. J Mol Biol 230:379-383, 1993.
127. Shindo H, Torigoe H, Sarai A: Thermodynamic and kinetic studies of DNA triplex formation of an oligohomopyrimidine and a matched duplex by filter binding assay. Biochemistry 32:8963-8969, 1993.
128. Ing NH, Beekman JM, Kessler DJ, et al: In vivo transcription of a progesterone-responsive gene is specifically inhibited by a triplex-forming oligonucleotide. Nucleic Acids Res 21:2789-2796, 1993.
129. Grigoriev M, Praseuth D, Guieysse A, et al: Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites. Proc Natl Acad Sci USA 90:3501-3505, 1993.
130. Havre PA, Gunther EJ, Gasparro FP, et al: Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen. Proc Natl Acad Sci USA 90:7879-7883, 1993.
131. Jones RJ, Swaminathan S, Milligan JF, et al: Oligonucleotides containing a covalent conformationally restricted phosphodiester analog for high-affinity triple helix formation: The riboacetal internucleotide linkage. J Am Chem Soc 115:9816-9817, 1993.
132. Radhakrishnan I, de los Santos C, Patel DJ: Nuclear magnetic reasonance structural studies of A•AT base triple alignments in intramolecular purine•purine‡pyrimidine DNA triplexes in solution. J Mol Biol 234:188-197, 1993.
133. Radhakrishnan I, Patel DJ: Solution structure of an intramolecular purine•purine•pyrimidine DNA triplex. J Am Chem Soc 115:1615-1617, 1993.
134. Radhakrishnan I, Patel DJ: Solution structure of a purine•purine•pyrimidine DNA triplex containing G•GC and T•AT triples. Structure 1:135-152, 1993.
135. Radhakrishnan I, Patel DJ, Priestley ES, et al: NMR structural studies on a nonnatural deoxyribonucleoside which mediates recognition of GC base pairs in pyrimidine•purine•pyrimidine DNA triplexes. Biochemistry 32:11228-31234, 1993.
136. Skoog JU, Maher LJ III: Relief of triple-helix-mediated promoter inhibition by elongating RNA polymerases. Nucleic Acids Res 21:4055-4058, 1993.
137. Olivas WM, Maher LJ: DNA recognition by alternate strand triple-helix formation: Affinities of oligonucleotides for a site in the human p53 gene. Biochemistry 33:983-991, 1994.
138. Olivas WM, Maher LJ III: Analysis of duplex DNA by triple helix formation: Application to detection of a p53 microdeletion. BioTechniques 16:128-132, 1994.
139. Rando RF, DePaolis L, Durland RH, et al: Inhibition of T7 and T3 RNA polymerase directed transcription elongation in vitro. Nucleic Acids Res 22:678-685, 1994.
140. Hélène C, Thuong NT, Saison-Behmoaras T, et al: Sequence-specific artificial endonucleases. Trends Biol Technol 7:310-315, 1989.
141. Koob M, Grimes E, Szybalski W: Conferring operator specificity on restriction endonucleases. Science 241:1084-1086, 1988.
142. Strobel SA, Dervan PB: Triple helix-mediated single-site enzymatic cleavage of megabase genomic DNA. Methods Enzymol 216:309-321, 1992.
143. Ferrin LJ, Camerini-Otero RD: Selective cleavage of human DNA: RecA-assisted restriction endonuclease (RARE) cleavage. Science 254:1494-1497, 1991.
144. Collier DA, Thuong NT, Hélène C: Sequence-specific bifunctional DNA ligands based on triple-helix-forming oligonucleotides inhibit restriction enzyme cleavage under physiological conditions J Am Chem Soc 113:1457-1458, 1991.
145. Kutyavin IV, Gamper HB, Gall AA, et al: Efficient, specific interstrand cross-linking of double-stranded DNA by a chlorambucil-modified, triplex-forming oligonucleotide. J Am Chem Soc 115:9303-9304, 1993.
146. Roy C: Inhibition of gene transcription by purine rich triplex forming oligodeoxyribonucleotides. Nucleic Acids Res 21:2845-2852, 1993.
147. Behe MJ: The DNA sequence of the human β-globin region is strongly biased in favor of long strings of contiguous purine or pyrmidine residues. Biochemistry 26:7870-7875, 1987.
148. Wang E, Malek S, Feigon I: Structure of a G•T•A triplet in an intramolecular DNA triplex. Biochemistry 31:4838-4846, 1992.
149. Ono A, Chen C-N, Kan L-S: DNA triplex formation of oligonucleotide analogues consisting of linker groups and octamer segments that have opposite sugar-phosphate backbone polarities. Biochemistry 30:9914-9921, 1991.
150. Froehler BC, Terhorst T, Shaw J-P, et al: Triple helix formation and cooperative binding by oligodeoxynucleotides with a 3′-3′ internucleotide junction. Biochemistry 31:1603-1609, 1992.
151. Jayasena SD, Johnston BH: Sequence limitations of triple helix formation by alternate-strand recognition. Biochemistry 32:2800-2807, 1993.
152. Asseline U, Thuong NT: Oligonucleotides tethered via nucleic bases: A potential new set of compounds for alternate strand triple-helix formation. Tet Lett 26:4173-4176, 1993.
153. Colocci N, Dervan PB: Cooperative binding of 8-mer oligonueleotides containing 5-(1-propynyl)-2′-deoxyuridine to adjacent DNA sites by triple-helix formation. J Am Chem Soc 116:785-786, 1994.
154. Gryaznov SM, Lloyd DH: Modulation of oligonncleotide duplex and triplex stability via hydrophobic interactions. Nucleic Acids Res 21:5909-5915, 1993.
155. Kessler DJ, Pettitt BM, Cheng Y-K, et al: Triple helix formation at distant sites: hybrid oligonucleotides containing a polymeric linker. Nucleic Acids Res 21:4810-4815, 1993.
156. Ellington AD, Szostak JW: In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-822, 1990.
157. Han H, Dervan PB: Sequence-specific recognition of double helical RNA and RNA•DNA by triple helix formation. Proc Natl Acad Sci USA 90:3806-3810, 1993.
158. Shaw J-P, Milligan JF, Krawczyk SH, et al: Specific, high-efficiency, triple-helix-mediated cross-linking to duplex DNA. J Am Chem Soc 113:7765-7766, 1991.
159. Latimer LJP, Hampel K, Lee JS: Synthetic repeating sequence DNAs containing phosphorothioates: Nuclease sensitivity and triplex formation. Nucleic Acids Res 17:1549-1561, 1989.
160. Kim S-G, Tsukahara S, Yokoyama S, et al: The influence of oligodeoxyribonucleotide phosphorothioate pyrimidine strands on triplex formation. FEBS Lett 314:29-32, 1992.
161. Callahan DE, Trapane TL, Miller PS, et al: Comparative circular dichroism and fluorescence studies of oligodeoxyribonucleotide and oligodeoxyribonucleoside methylphosphonate pyrimidine strands in duplex and triplex forms. Biochemistry 30:1991.
162. Fisher TL, Terhorst T, Cao X, et al: Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res 21:3857-3865, 1993.
163. Olivas WM, Maher LJ: Competitive triplex/quadruplex equilibria involving guanine-rich oligonucleotides. Biochemistry 34:278-284, 1995.
164. Olivas WM, Maher LJ: Overcoming potassium-mediated triplex inhibition. Nucleic Acids Res 23:1936-1941, 1995.
165. Semerad CL, Maher LJ: Exclusion of RNA strands from a purine motif triple helix. Nucleic Acids Res 22:5321-5325, 1994.